Tokyo Nucleic Acid Synthesis

Tokyo Nucleic Acid Synthesis

Innovative DNA-based cancer therapies activating the immune system.

HQ location
Tokyo, Japan
Website
Launch date
Employees
Enterprise value
$5—7m
  • Edit
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads